Adolor and Pfizer Collaborate on Delta Opioid Agonists

By Business Review Editor

Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)

Published: 8 Jan-2008

DOI: 10.3833/pdr.v2008.i91.231     ISSN: 1756-7874

Section: Research & Development



Adolor and Pfizer entered into worldwide co-development agreement to develop and commercialize Adolor’s ADL5859 which is in phase 2 clinical trials for treating inflammatory pain associated with rheumatoid arthritis and acute post-dental surgery pain and ADL5747 which is in preclinical development for treating pain...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details